CO7131359A2 - Agentes de imagen para detectar disfunción neurológica - Google Patents
Agentes de imagen para detectar disfunción neurológicaInfo
- Publication number
- CO7131359A2 CO7131359A2 CO14255692A CO14255692A CO7131359A2 CO 7131359 A2 CO7131359 A2 CO 7131359A2 CO 14255692 A CO14255692 A CO 14255692A CO 14255692 A CO14255692 A CO 14255692A CO 7131359 A2 CO7131359 A2 CO 7131359A2
- Authority
- CO
- Colombia
- Prior art keywords
- compound
- mammal
- brain tissue
- imaging agents
- neurological dysfunction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Abstract
La presente invención se refiere a compuestos ymétodos para diagnosticar la Enfermedad de Alzheimer o unapredisposición a la misma en un mamífero, el método comprendeadministrar al mamífero una cantidad para el diagnósticoefectivo de un compuesto radioetiquetado, en donde el compuestose selecciona del grupo que consiste del carbazol esradioetiquetados y derivados del mismo y derivados detriazoles, permitiendo que el compuesto se distribuya en eltejido cerebral, y formando imagen del tejido cerebral, endonde un incremento en el enlace del compuesto al tejidocerebral comparado a un nivel de control normal de unión indicaque el mamífero sufre de o está en riesgo de desarrollar laEnfermedad de Alzheimer.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/477,095 US8932557B2 (en) | 2008-02-14 | 2012-05-22 | Imaging agents for detecting neurological dysfunction |
Publications (1)
Publication Number | Publication Date |
---|---|
CO7131359A2 true CO7131359A2 (es) | 2014-12-01 |
Family
ID=47146722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO14255692A CO7131359A2 (es) | 2012-05-22 | 2014-11-20 | Agentes de imagen para detectar disfunción neurológica |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2852572B1 (es) |
JP (1) | JP5976206B2 (es) |
KR (1) | KR101609504B1 (es) |
CN (2) | CN107011342A (es) |
AU (1) | AU2012381042B2 (es) |
CA (1) | CA2873963C (es) |
CO (1) | CO7131359A2 (es) |
ES (1) | ES2792830T3 (es) |
WO (1) | WO2013176698A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10662193B2 (en) * | 2014-01-21 | 2020-05-26 | Ac Immune Sa | Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins |
EP3134409B1 (en) * | 2014-04-22 | 2020-02-12 | Université de Montréal | Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells |
JP6529986B2 (ja) | 2014-05-13 | 2019-06-12 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 重水素化ヘテロ環式化合物及びイメージング剤としてのその使用 |
SG11201705727TA (en) * | 2015-02-02 | 2017-08-30 | Ucb Biopharma Sprl | 9h-pyrrolo-dipyridine derivatives |
CN107207499A (zh) * | 2015-03-04 | 2017-09-26 | 国立大学法人京都大学 | 经放射性碘标记的吡啶并[1,2‑a]苯并咪唑衍生物化合物 |
TW201707726A (zh) * | 2015-08-19 | 2017-03-01 | 國立大學法人京都大學 | 放射性鹵素標誌吡啶并[1,2-a]苯并咪唑衍生物化合物 |
WO2017083198A1 (en) | 2015-11-13 | 2017-05-18 | Eli Lilly And Company | Azetidine derivatives for tau imaging |
WO2018015549A1 (en) | 2016-07-22 | 2018-01-25 | Ac Immune S.A. | Compounds for imaging tau protein aggregates |
WO2018015546A1 (en) | 2016-07-22 | 2018-01-25 | Ac Immune S.A. | Compounds for imaging tau protein aggregates |
WO2018024642A1 (en) | 2016-08-02 | 2018-02-08 | Ucb Biopharma Sprl | 9h-pyrrolo-dipyridine derivatives |
WO2018024643A1 (en) | 2016-08-02 | 2018-02-08 | Ucb Biopharma Sprl | 9h-pyrrolo-dipyridine derivatives |
CA3209295A1 (en) * | 2016-11-01 | 2018-06-07 | Arvinas, Inc. | Tau-protein targeting protacs and associated methods of use |
CN109884194A (zh) * | 2017-12-06 | 2019-06-14 | 新疆维吾尔药业有限责任公司 | 一种药用植物的分离方法及其产品和应用 |
EP3743426A1 (en) | 2018-01-24 | 2020-12-02 | AC Immune SA | Azacarboline compounds for the detection of tau aggregates |
US11306089B2 (en) | 2018-01-24 | 2022-04-19 | Life Molecular Imaging Limited | Gamma-carboline compounds for the detection of Tau aggregates |
CN108409634B (zh) * | 2018-05-10 | 2021-04-27 | 曲阜师范大学 | 咔唑类荧光胺类化合物标记试剂、合成和应用 |
JP7297053B2 (ja) | 2018-08-20 | 2023-06-23 | アルビナス・オペレーションズ・インコーポレイテッド | 神経変性疾患を治療するためのe3ユビキチンリガーゼ結合活性を有するキメラ(protac)化合物を標的とし、アルファ-シヌクレインタンパク質を標的とするタンパク質分解 |
KR102215255B1 (ko) * | 2019-06-12 | 2021-02-15 | 한국과학기술연구원 | 타우 응집체에 선택적으로 결합하는 형광 탐침자로서 유효한 신규 화합물 및 이의 제조 방법 |
WO2021011913A1 (en) | 2019-07-17 | 2021-01-21 | Arvinas Operations, Inc. | Tau-protein targeting compounds and associated methods of use |
US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
CN114539250B (zh) * | 2022-03-04 | 2023-08-29 | 上海裕兰生物科技有限公司 | 一种阿尔兹海默症PET-tau示踪剂的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1771176A2 (en) * | 2004-06-30 | 2007-04-11 | Smithkline Beecham Corporation | Methods and compositions |
FR2885905A1 (fr) * | 2005-05-23 | 2006-11-24 | Trophos Sa | Nouveaux composes chimiques et leurs utilisations comme medicament |
DE102006062203A1 (de) * | 2006-12-22 | 2008-06-26 | Curacyte Discovery Gmbh | Substituierte 5H-Pyrimido[5,4-b]indole als Induktoren der Apoptose bei B-CLL Zellen |
WO2008132454A1 (en) * | 2007-04-26 | 2008-11-06 | Ge Healthcare Limited | Carbolines and their use as imaging agents |
KR20100135235A (ko) * | 2008-02-14 | 2010-12-24 | 지멘스 메디컬 솔루션즈 유에스에이, 인크. | 신경학적 기능이상을 검출하기 위한 조영제 |
US8420052B2 (en) * | 2008-07-24 | 2013-04-16 | Siemens Medical Solutions Usa, Inc. | Imaging agents useful for identifying AD pathology |
JP2012051804A (ja) * | 2008-12-26 | 2012-03-15 | Kyoto Univ | Eg5阻害剤 |
US8691187B2 (en) * | 2009-03-23 | 2014-04-08 | Eli Lilly And Company | Imaging agents for detecting neurological disorders |
WO2010111303A2 (en) * | 2009-03-23 | 2010-09-30 | Siemens Medical Solutions Usa, Inc. | Imaging agents for detecting neurological disorders |
US10639608B2 (en) * | 2010-04-08 | 2020-05-05 | Siemens Medical Solutions Usa, Inc. | System, device and method for preparing tracers and transferring materials during radiosynthesis |
JP5585382B2 (ja) * | 2010-10-22 | 2014-09-10 | コニカミノルタ株式会社 | 有機エレクトロルミネッセンス素子、照明装置及び表示装置 |
-
2012
- 2012-10-25 ES ES12783780T patent/ES2792830T3/es active Active
- 2012-10-25 EP EP12783780.5A patent/EP2852572B1/en active Active
- 2012-10-25 CN CN201611136351.0A patent/CN107011342A/zh active Pending
- 2012-10-25 CA CA2873963A patent/CA2873963C/en active Active
- 2012-10-25 JP JP2015513993A patent/JP5976206B2/ja active Active
- 2012-10-25 CN CN201280073373.0A patent/CN104781234A/zh active Pending
- 2012-10-25 WO PCT/US2012/061912 patent/WO2013176698A1/en active Application Filing
- 2012-10-25 KR KR1020147032388A patent/KR101609504B1/ko active IP Right Grant
- 2012-10-25 AU AU2012381042A patent/AU2012381042B2/en active Active
-
2014
- 2014-11-20 CO CO14255692A patent/CO7131359A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2852572B1 (en) | 2020-04-01 |
KR20150002854A (ko) | 2015-01-07 |
CA2873963A1 (en) | 2013-11-28 |
JP2015517572A (ja) | 2015-06-22 |
WO2013176698A1 (en) | 2013-11-28 |
KR101609504B1 (ko) | 2016-04-05 |
ES2792830T3 (es) | 2020-11-12 |
CN107011342A (zh) | 2017-08-04 |
EP2852572A1 (en) | 2015-04-01 |
AU2012381042A1 (en) | 2014-11-20 |
JP5976206B2 (ja) | 2016-08-23 |
AU2012381042B2 (en) | 2015-10-01 |
CN104781234A (zh) | 2015-07-15 |
CA2873963C (en) | 2017-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO7131359A2 (es) | Agentes de imagen para detectar disfunción neurológica | |
CY1125258T1 (el) | Νεοι παραγοντες απεικονισης για ανιχνευση νευρολογικης δυσλειτουργιας | |
UY30112A1 (es) | Nuevos benzotiazoles sustitidos por heteroarilo | |
BR112014012822A8 (pt) | Radioligantes rotulados com flúor-18 e carbono-11 para imagiologia por tomografia por emissão de pósitrons (pet) para lrrk2 | |
BR112016028345A2 (pt) | composto, composição farmacêutica, métodos para inibir agregação de tau em um mamífero e para avaliar depósitos de tau em um paciente, e, uso de um composto. | |
WO2010011964A3 (en) | Imaging agents useful for identifying ad pathology | |
UA116774C2 (uk) | Інгібітори серин/треонінкінази | |
EA201171397A1 (ru) | Иммунологическое нацеливание на патологические тау-протеины | |
WO2009117728A3 (en) | Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders | |
AR079641A1 (es) | Compuestos para el diagnostico por imagenes de la muerte de las celulas por apotosis | |
MX2013010343A (es) | Composicion y metodos para el transplante de microbiota de colon. | |
PE20160159A1 (es) | Derivados de diazacarbazol como ligandos de tau para pet | |
BR112016015236A8 (pt) | composto,composição farmacêutica,uso de um composto,método de inibição e método para tratar ou aliviar a gravidade de uma doença. | |
PE20151771A1 (es) | Composiciones nutricionales que contienen un componente neurologico y los usos del mismo | |
MX357761B (es) | Métodos para tratar la enfermedad de alzheimer, enfermedad de huntington, autismo u otros trastornos. | |
JP2014198718A5 (es) | ||
AR114029A2 (es) | Compuestos adecuados como precursores de compuestos que son útiles para obtener imágenes de depósitos amiloides, usos y procesos | |
BR112014014960A2 (pt) | métodos para o diagnóstico da doença de alzheimer | |
BR112015027015A2 (pt) | derivados de 2-fenil ou 2-hetaril imidazol[1,2-a]piridina | |
NI201800031A (es) | Derivados de oxima de cromona penetrante del cerebro para la terapia de disquinesia inducida por levodopa | |
BR112019000946A2 (pt) | compostos para imagiologia dos agregados da proteína tau | |
BR112017009010A2 (pt) | moduladores potentes de gama-secretase | |
WO2010051196A8 (en) | Novel substituted azabenzoxazoles | |
MX2009009113A (es) | Nuevos indoles 2-heteroaril sustituidos 695. | |
GB201115937D0 (en) | 18F-labelled compounds for use as positron emission imaging agents |